Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,530.00    -205.00 (-5.49%)
Bid:
3,525.00
Ask:
3,545.00
Spread: 20.00 (0.567%)
Market Cap: $927.20b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Report on Share Repurchase Results

17 Feb 2025 12:16

RNS Number : 3816X
Samsung Electronics Co. Ld
17 February 2025
 

Report on Share Repurchase Results

 

1. Details of repurchase (unit: KRW, share)

- Share repurchase period: November 20, 2024-February 13, 2025

 * The report submission date : November 18, 2024

 * The above period is based on contract date.

- Common shares (Registered common shares)

Order quantity: 50,444,628 shares / Acquired quantity: 50,144,628 shares

Acquisition price per share: KRW 54,526 / Total acquisition amount: KRW mil. 2,734,200

- Other shares (Registered preferred shares)

Order quantity: 6,952,036 shares / Acquired quantity: 6,912,036 shares

Acquisition price per share: KRW 45,500 / Total acquisition amount: KRW mil. 314,497

 

2. Consistency between planned and actual acquisition

- Planned quantity : Common shares: 50,144,628 / Other shares: 6,912,036

- Acquired quantity : Common shares: 50,144,628 / Other shares: 6,912,036

 

3. Holding status of treasury shares after acquisition (as of February 17, 2025)

Quantity

Ratio

Amount(KRW mil)

Common shares

50,144,628

0.84%

2,734,200

Other shares

 6,912,036

0.84%

314,497

Total

57,056,664

0.84%

3,048,697

* Common shares amount to 50,144,628 shares and other shares amount to 6,912,036 shares acquired in this share repurchase program are included in the above 3. Holding status of treasury shares after acquisition, however, they are subject to cancellation.

 

4. Changes in share holdings by major shareholders before and after acquisition (as of February 13, 2025)

Share Type

Report date of acquisition

End date of acquisition

Reason for change

Samsung Life

Insurance

Common

508,157,148

503,904,843

Sales through on-market transactions

Other

43,950

43,950

-

Samsung Life

Insurance

(special account)

Common

5,569,527

5,435,337

Sales through on-market transactions

Other

372,566

319,536

Sales through on-market transactions

Total

Common

513,726,675

509,340,180

-

Other

416,516

363,486

-

Sub total

514,143,191

509,703,666

-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFLFFWEISEIE
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.